17:25 , Aug 17, 2018 |  BC Week In Review  |  Financial News

Crossover investors join Orchard's syndicate in $150M series C

Gene therapy company Orchard Therapeutics Ltd. (London, U.K.) raised $150 million on Aug. 13 in a series C round led by Deerfield Management. Also participating were new investors RA Capital, Venrock, Foresite Capital, Perceptive Advisors,...
19:22 , Aug 13, 2018 |  BC Extra  |  Financial News

Crossover investors join Orchard's syndicate in $150M series C

Gene therapy company Orchard Therapeutics Ltd. (London, U.K.) raised $150 million in a series C round led by Deerfield Management. Also participating were new investors RA Capital, Venrock, Foresite Capital, Perceptive Advisors, Cormorant Asset Management,...
17:26 , Jul 20, 2018 |  BC Week In Review  |  Financial News

DFJ leads Verge Genmics' $32M series A round

Neuroscience company Verge Genomics Inc. (San Francisco, Calif.) raised $32 million in a series A round led by DFJ on July 16. New investors included the corporate venture fund of WuXi AppTec Co. Ltd. (Shanghai:603259),...
16:35 , Jul 20, 2018 |  BC Week In Review  |  Financial News

Fibrotic disease company Pliant raises $62M series B

Fibrosis play Pliant Therapeutics Inc. (Redwood City, Calif.) raised $62 million on July 16 in an untranched series B round led by Cowen Healthcare Investments. Fellow new investors Eventide Asset Management, Schroder Adveq, Menlo Ventures,...
17:45 , Jul 18, 2018 |  BioCentury  |  Finance

Fibrosis firsts

Pliant Therapeutics Inc.’s preclinical models and discovery technology prompted Cowen Healthcare Investments and Menlo Ventures to choose the company as their first fibrosis investments. Cowen led Pliant’s untranched $62 million series B round on Monday, joined...
16:45 , Jul 16, 2018 |  BC Extra  |  Financial News

Fibrotic disease company Pliant raises $62M series B

Fibrosis play Pliant Therapeutics Inc. (Redwood City, Calif.) raised $62 million in an untranched series B round led by Cowen Healthcare Investments. Fellow new investors Eventide Asset Management, Schroder Adveq, Menlo Ventures, SCubed Capital, Agent...
11:01 , Jul 16, 2018 |  BC Extra  |  Financial News

DFJ leads Verge Genomics' $32M series A round

Neuroscience company Verge Genomics Inc. (San Francisco, Calif.) raised $32 million in a series A round led by DFJ. New investors included the corporate venture fund of WuXi AppTec Co. Ltd. (Shanghai:603259), ALS Investment Fund,...
11:00 , Jul 16, 2018 |  BioCentury  |  Finance

AI on the Verge

For its $32 million series A round, artificial intelligence-guided neurology company Verge Genomics Inc. sought an investor syndicate that reflected its multidisciplinary mind-set. DFJ led the round. New investors included the corporate venture fund of WuXi...
19:48 , Jun 29, 2018 |  BioCentury  |  Finance

Carisma’s attraction

Macrophage immunotherapy play Carisma Therapeutics Inc. has developed biomarkers that it can use to track macrophage activity and tumor response in preclinical and clinical studies, leading Wellington Partners to join its $53 million series A...
14:52 , Jun 29, 2018 |  BC Week In Review  |  Financial News

AbbVie Ventures, HealthCap lead Carisma's $53M series A

Macrophage immunotherapy company Carisma Therapeutics Inc. (Philadelphia, Pa.) raised $53 million in a series A round led by existing investors AbbVie Ventures and HealthCap. Existing investors IP Group plc (LSE:IPO), Penn Medicine and Grazia Equity,...